Physician organizations have an ethical obligation to advocate for general improvement of public health, even if it is sometimes at the expense of interests of medical professionals.
Mark McClellan, Commissioner of Food and Drugs, discusses pharmaceutical company research and the problems faced by funding for public health programs.
Physicians of patients who request physician-assisted suicide should not avoid the subject and should try to discuss the patients' specific concerns and fears with them.
Physicians need to inform parents about the limited effectiveness of growth hormone therapy in satisfying the treatment goals of children with idiopathic short stature.